This trial will compare two different antibiotics to see which one is better at preventing surgical site infections after pancreatoduodenectomy.
1 Primary · 0 Secondary · Reporting Duration: 30 days
Active Control
Experimental Treatment
962 Total Participants · 2 Treatment Groups
Primary Treatment: Piperacillin-tazobactam · No Placebo Group · Phase 3
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: